MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RGNX has $525,203K in assets. $363,751K in debts. $58,802K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
266.49%
Cash Ratio
47.20%
Debt to Asset Ratio
69.26%
Assets Breakdown
    • Marketable securities
    • Total property and equipment
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty monetization liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
58,802 79,558
Marketable securities
215,403 243,740
Accounts receivable
25,347 20,199
Prepaid expenses
12,943 10,776
Other current assets
19,472 19,479
Total current assets
331,967 373,752
Marketable securities
27,838 40,296
Accounts receivable
2,765 1,584
Total property and equipment
191,054 -
Accumulated depreciation and amortization
83,539 -
Property and equipment, net
107,515 111,017
Operating lease right-of-use assets
48,820 50,469
Restricted cash
2,030 2,030
Other assets
4,268 1,879
Total assets
525,203 581,027
Accounts payable
22,266 21,655
Accrued expenses and other current liabilities
38,316 35,557
Deferred revenue
13,195 13,977
Operating lease liabilities
9,073 8,049
Royalty monetization liabilities
41,718 40,302
Total current liabilities
124,568 119,540
Deferred revenue
21,186 23,804
Operating lease liabilities
67,433 69,647
Royalty monetization liabilities
149,916 153,693
Other liabilities
648 664
Total liabilities
363,751 367,348
Common stock 0.0001 par value 100,000 shares authorized at september 30, 2025 and december 31, 2024 50,619 and 49,549 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
5 5
Additional paid-in capital
1,220,977 1,211,361
Accumulated other comprehensive loss
-652 -750
Accumulated deficit
-1,058,878 -996,937
Total stockholders equity
161,452 213,679
Total liabilities and stockholders equity
525,203 581,027
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total property andequipment$191,054K Other current assets$19,472K Prepaid expenses$12,943K Accounts receivable$25,347K Marketable securities$215,403K Cash and cashequivalents$58,802K Other assets$4,268K Restricted cash$2,030K Operating leaseright-of-use assets$48,820K Property and equipment,net$107,515K Accounts receivable$2,765K Marketable securities$27,838K Total current assets$331,967K Accumulated depreciationand amortization$83,539K Total assets$525,203K Total liabilities andstockholders equity$525,203K Total stockholdersequity$161,452K Total liabilities$363,751K Accumulated deficit-$1,058,878K Accumulated othercomprehensive loss-$652K Additional paid-in capital$1,220,977K Other liabilities$648K Royalty monetizationliabilities$149,916K Operating leaseliabilities$67,433K Deferred revenue$21,186K Total currentliabilities$124,568K Common stock 0.0001 parvalue 100,000 shares...$5K Royalty monetizationliabilities$41,718K Operating leaseliabilities$9,073K Deferred revenue$13,195K Accrued expenses andother current...$38,316K Accounts payable$22,266K

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX)